[Agranulocytosis and toxic hepatic dystrophy during treatment with tuberculostatic drugs].
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D000995:Antitubercular Agents / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000150:complications; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications / Q000209:etiology*; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000150:complications; D011718:Pyrazinamide / Q000009:adverse effects
D000995:Antitubercular Agents; D011718:Pyrazinamide
Agranulotsitoz i toksicheskaia distrofiia pecheni pri lechenii tuberkulostaticheskimi preparatami.